Synairgen (SNG) News Today GBX 4.68 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 7:48 AM | americanbankingnews.comSynairgen (LON:SNG) Stock Crosses Below Two Hundred Day Moving Average of $5.67May 27, 2024 | lse.co.ukSuominen Ord Share ChatMay 22, 2024 | lse.co.ukPrimorus Inv. Share ChatApril 4, 2024 | morningstar.comSonagi SGPS SA SNGFebruary 8, 2024 | finance.yahoo.comSynairgen plc (SYGGF) Stock Historical Prices & Data - Yahoo FinanceFebruary 7, 2024 | uk.finance.yahoo.comSynairgen plc (SNG.L)January 22, 2024 | finance.yahoo.comCompanies Like Synairgen (LON:SNG) Are In A Position To Invest In GrowthDecember 23, 2023 | morningstar.comSynairgen PLC SYGGFDecember 16, 2023 | morningstar.comSynairgen PLC OMYDecember 16, 2023 | morningstar.comSynairgen PLC SNGNovember 22, 2023 | morningstar.comSNGN Romgaz SA SNGOctober 11, 2023 | marketwatch.comSynairgen Finance Chief John Ward Steps Down; Colliver Named as ReplacementOctober 11, 2023 | proactiveinvestors.comSynairgen appoints new CFO as incumbent bows out after nearly 20 yearsSeptember 21, 2023 | proactiveinvestors.comSynairgen takes targeted approach with lead assetSeptember 21, 2023 | finance.yahoo.comSynairgen looking beyond COVID in fight against respiratory illnessJune 13, 2023 | finance.yahoo.comWe Think Synairgen (LON:SNG) Needs To Drive Business Growth CarefullyJune 9, 2023 | finance.yahoo.comSNG.L - Synairgen plcJanuary 4, 2023 | finance.yahoo.comCompanies Like Synairgen (LON:SNG) Could Be Quite RiskyOctober 4, 2022 | proactiveinvestors.comFTSE 100 jumps 140 points as L&G statement reassures - Proactive Investors USAOctober 4, 2022 | finance.yahoo.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19October 4, 2022 | businesswire.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19 - Business WireSeptember 30, 2022 | marketwatch.comSynairgen Shares Drop Amid Phase 3 Study Issues; Pretax Loss Narrows - MarketWatchSeptember 29, 2022 | lse.co.ukEARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens | Financial News - London South EastSeptember 29, 2022 | proactiveinvestors.comTesla appoints Airbnb co-founder Joe Gebbia to board - Proactive Investors USASeptember 20, 2022 | finance.yahoo.comSynairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022September 20, 2022 | marketscreener.comSynairgen's SNG001 Reduces Long COVID-19 Symptoms In Follow-up Visits After Late-stage Trial - Marketscreener.comSeptember 20, 2022 | proactiveinvestors.comSynairgen to present data showing drug lowers risk of long Covid symptoms - Proactive Investors USASeptember 7, 2022 | lse.co.ukIN BRIEF: Synairgen shares rise as positive data found for COPD | Financial News - London South EastSeptember 7, 2022 | finance.yahoo.comSynairgen announces positive findings from analysis of lung samples from the SG015 trial of SNG001 in virally infected COPD patientsSeptember 7, 2022 | marketwatch.comSynairgen Gets Positive Data From Trial of Respiratory Drug Treatment - MarketWatchSeptember 7, 2022 | lse.co.ukSynairgen unveils positive clinical trial data | Financial News - London South EastSeptember 7, 2022 | proactiveinvestors.comSynairgen reports positive data from respiratory viral infection drug - Proactive Investors USASeptember 5, 2022 | proactiveinvestors.comFTSE 100 opens lower as oil giants push ahead - Proactive Investors USASeptember 5, 2022 | morningstar.co.ukTRADING UPDATES: Bradda wins drilling approval; Oakley invests in vLex - MorningstarSeptember 5, 2022 | proactiveinvestors.comSynairgen to play key role in respiratory viral infection study - Proactive Investors USAAugust 5, 2022 | fool.co.ukThe Synairgen share price crashes again as US study is haltedJune 29, 2022 | globenewswire.comChronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswireMay 31, 2022 | finance.yahoo.comCan Synairgen (LON:SNG) Afford To Invest In Growth?May 27, 2022 | morningstar.co.ukIN BRIEF: Synairgen shares fall as loss widens on higher costs - MorningstarMay 25, 2022 | lse.co.ukIN BRIEF: Synairgen shares fall as loss widens on higher costs | Financial News - London South EastMay 25, 2022 | proactiveinvestors.comSynairgen "working in haste" to plan new lung infection trials - Proactive Investors USAMay 19, 2022 | ca.proactiveinvestors.comSynairgen PLC on presenting at the ATS conference in San FranciscoMay 16, 2022 | businesswire.comSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022 - Business WireMay 16, 2022 | finance.yahoo.comSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022May 16, 2022 | marketwatch.comSynairgen Shares Rise on Positive Analysis of Phase 3 Covid-19 Treatment Trial - MarketWatchApril 25, 2022 | fool.co.ukWhat's next for the Synairgen (LON: SNG) share price? - The Motley Fool UK - Motley Fool UKApril 6, 2022 | finance.yahoo.comSynairgen to present further analysis of Phase 3 SPRINTER trial in hospitalised patients with COVID-19 at the ATS 2022 International Conference - Yahoo FinanceApril 5, 2022 | finance.yahoo.comSynairgen to present further analysis of Phase 3 SPRINTER trial in hospitalised patients with COVID-19 at the ATS 2022 International ConferenceApril 5, 2022 | proactiveinvestors.comSynairgen to present data from phase III Covid trial at leading industry conference - Proactive Investors USAMarch 17, 2022 | morningstar.co.ukAIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted - Morningstar Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview SNG Media Mentions By Week SNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNG News Sentiment▼0.000.62▲Average Medical News Sentiment SNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNG Articles This Week▼10▲SNG Articles Average Week Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arecor Therapeutics News Today C4X Discovery News Today Ondine Biomedical News Today OptiBiotix Health News Today Hemogenyx Pharmaceuticals News Today BiVictriX Therapeutics News Today ImmuPharma News Today Roquefort Therapeutics News Today Destiny Pharma News Today ValiRx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SNG) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
